Efficacy of QR678 Neo Hair Growth Factor Formulation for the Treatment of Hair Loss in COVID-19-Induced Persistent Telogen Effluvium: A Prospective, Clinical, Single-Blind Study

QR678 and QR678 Neo treatments, combined with corticosteroid injections, work better for alopecia areata than corticosteroid injections alone.

Intradermal injections improve hair density and thickness better, while derma roller is more convenient.

COVID-19 can cause over 50 long-term symptoms, with fatigue and headache being the most common.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

QR 678 and QR678 Neo treatments are effective for hair loss in women with PCOS.

QR678 treatments were more effective and comfortable for male hair loss than PRP treatments.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Indian dermatologists recommend treating common hair loss with a balanced diet, stress reduction, mild shampoos, and sometimes minoxidil and supplements.

The QR 678 hair growth treatment was safe and effective for hair regrowth in men and women.

Dengue fever can cause a temporary type of hair loss called telogen effluvium.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Chronic hair shedding may be caused by less variation in hair growth times and might stop on its own after several years.

Hair loss that spreads out can often fix itself or be treated by finding and handling the cause.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Critically ill patients may experience temporary hair loss after a fever.